Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02454803 · ClinicalTrials.gov registry record
Attainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real Life Practice
A clinical trial, sponsored by Ipsen.
- Completed
- Registry status
- 1,004
- Enrollment target
NCT02454803: Completed study, sponsored by Ipsen.
NCT02454803 is a clinical trial that has completed, run by Ipsen. The registered enrollment target is 1,004 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02454803 has completed, sponsored by Ipsen.
- COMPLETED
- Registry status
- 1,004 participants
- Enrollment target
Study Summary
The primary purpose for this study is to understand the effect of botulinum toxin as a treatment integrated in the management of spasticity (stiffness) in the arm and/or hand, arising from any neurological condition. The study will look at the types of goals that people choose for treatment, and the extent to which these are achieved in different individuals.
Primary Outcome
Goal attainment will be recorded on a five point numerical scale (range -2 to +2) and goal scores combined to give an aggregated T score.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,004 participants |
| Start Date | 2015-01 |
| Est. Completion | 2019-06-03 |
What the finished NCT02454803 record still lists
NCT02454803 is an observational study that tracks outcomes without assigning an intervention. Its 1,004 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02454803 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02454803 about?
NCT02454803 is a clinical study titled "Attainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real Life Practice". The primary purpose for this study is to understand the effect of botulinum toxin as a treatment integrated in the management of spasticity (stiffness) in the arm and/or hand, arising from any neurological condition. The study will look at the types of goals that people choose for treatment, and the...
What is the current status of trial NCT02454803?
This trial is currently completed. The enrollment target is 1,004 participants. The study started on 2015-01. Estimated completion is 2019-06-03.
Who is sponsoring clinical trial NCT02454803?
This trial is sponsored by Ipsen, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04389632 · 1,006 participants · Phase 1
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- NCT06207864 · 1,001 participants · NA
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
- NCT07191782 · 1,008 participants · NA
Examining the Efficacy of the PRAISE With Coaching Program
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia